In October 2022, Ambuja Cements issued warrants totalling ₹20,000 crore to the Adanis on a preferential basis at ₹418.8 per share. The company received ₹5,000 crore, or 25%, of the warrant issue as the mandatory upfront payment.
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the